Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Global Cord Blood stock

Learn how to easily invest in Global Cord Blood stock.

Global Cord Blood is a diagnostics & research business based in the US. Global Cord Blood shares (CO) are listed on the NYSE and all prices are listed in US Dollars. Global Cord Blood employs 1,202 staff and has a trailing 12-month revenue of around $1.2 billion.

How to buy Global Cord Blood stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – CO. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Best for beginners

Finder Award


  • Easy to use platform with $0 stock trading & no annual fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100

Promoted for options trading


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+

Global Cord Blood stock price (NYSE: CO)

Use our graph to track the performance of CO stocks over time.

Global Cord Blood shares at a glance

Information last updated 2023-03-18.
Latest market close$2.99
52-week range$2.03 - $4.08
50-day moving average $2.99
200-day moving average $2.84
Wall St. target price$15.00
PE ratio 5.0637
Dividend yield $0 (0%)
Earnings per share (TTM) $0.59

Buy Global Cord Blood stocks from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 7 of 7
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
Stocks, Options, ETFs, Cryptocurrency
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency, Futures
Get $100 - $2,000
when you you open and fund an account with $5,000 to $100,000+
Highly commended for Best Derivatives Trading Platform award.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
Stocks, ETFs, Cryptocurrency, Alternatives, Treasury Bills
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Diversify your portfolio by trading stocks, ETFs, T-Bills, crypto, rare collectibles and more.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs, Treasury Bills
Get $50 - $700
when you open and fund an account with $10,000 - $250,000+
Stocks, Bonds, Options, Mutual funds, ETFs, Futures
Get up to $600 or more
when you open and fund a new account.
E*TRADE offers commission-free stocks, access to mutual funds and advanced trading tools. Other fees apply.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Global Cord Blood stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Global Cord Blood price performance over time

Historical closes compared with the close of $2.99 from 2023-03-20

1 week (2023-03-14) 2.99
1 month (2023-02-22) 2.99
3 months (2022-12-22) 2.99
6 months (2022-09-22) 34.68%
1 year (2022-03-22) -24.87%
2 years (2021-03-22) -36.11%
3 years (2020-03-20) 3.39
5 years (2018-03-21) 11.7528

Is Global Cord Blood stock undervalued or overvalued?

Valuing Global Cord Blood stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Global Cord Blood's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Global Cord Blood financials

Revenue TTM $1.2 billion
Operating margin TTM 48.97%
Gross profit TTM $1.1 billion
Return on assets TTM 4.63%
Return on equity TTM 10.99%
Profit margin 40.3%
Book value $40.14
Market capitalisation $400.1 million

TTM: trailing 12 months

Global Cord Blood share dividends

We're not expecting Global Cord Blood to pay a dividend over the next 12 months.

Global Cord Blood share price volatility

Over the last 12 months, Global Cord Blood's shares have ranged in value from as little as $2.03 up to $4.08. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Global Cord Blood's is -0.0417. This would suggest that Global Cord Blood's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Global Cord Blood has bucked the trend.

Global Cord Blood overview

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd. .

Frequently asked questions

What percentage of Global Cord Blood is owned by insiders or institutions?
Currently 61.551% of Global Cord Blood shares are held by insiders and 22.154% by institutions.
How many people work for Global Cord Blood?
Latest data suggests 1,202 work at Global Cord Blood.
When does the fiscal year end for Global Cord Blood?
Global Cord Blood's fiscal year ends in March.
Where is Global Cord Blood based?
Global Cord Blood's address is: Bank of China Tower, Central, Hong Kong
What is Global Cord Blood's ISIN number?
Global Cord Blood's international securities identification number is: US6986591096
What is Global Cord Blood's CUSIP number?
Global Cord Blood's Committee on Uniform Securities Identification Procedures number is: G39342103

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site